<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Loss of expression and function of the E-cadherin/catenin membrane complex can result in <z:mp ids='MP_0000340'>loss of cell</z:mp> <z:e sem="disease" ids="C0001511" disease_type="Disease or Syndrome;Acquired Abnormality" abbrv="">adhesion</z:e> and contribute to invasive or metastatic potential in <z:mp ids='MP_0002038'>carcinomas</z:mp> </plain></SENT>
<SENT sid="1" pm="."><plain>The aim of this study was to examine the expression of alpha- and beta-catenin and E-cadherin in <z:hpo ids='HP_0100580'>Barrett's esophagus</z:hpo> with and without <z:mpath ids='MPATH_589'>dysplasia</z:mpath> and in esophageal <z:mp ids='MP_0009308'>adenocarcinomas</z:mp> and to identify any relationship with <z:e sem="disease" ids="C0598934" disease_type="Neoplastic Process" abbrv="">tumor growth</z:e> pattern and clinical outcome </plain></SENT>
<SENT sid="2" pm="."><plain>Immunoperoxidase staining for alpha- and beta-catenin and E-cadherin was performed on specimens of <z:hpo ids='HP_0100580'>Barrett's esophagus</z:hpo> with and without <z:mpath ids='MPATH_589'>dysplasia</z:mpath> and on 54 esophageal <z:mp ids='MP_0009308'>adenocarcinoma</z:mp> specimens </plain></SENT>
<SENT sid="3" pm="."><plain>Membranous staining for <z:hpo ids='HP_0000001'>all</z:hpo> of the components was seen in <z:mpath ids='MPATH_458'>normal</z:mpath> gastric and esophageal mucosa </plain></SENT>
<SENT sid="4" pm="."><plain>Abnormal expression of beta-catenin, alpha-catenin, and E-cadherin was significantly associated with higher degrees of <z:mpath ids='MPATH_589'>dysplasia</z:mpath> in <z:hpo ids='HP_0100580'>Barrett's esophagus</z:hpo> </plain></SENT>
<SENT sid="5" pm="."><plain>Fourteen of 16 cases of high grade <z:mpath ids='MPATH_589'>dysplasia</z:mpath> and 7 of 7 cases of intramucosal <z:mp ids='MP_0002038'>carcinoma</z:mp> showed abnormal expression of beta-catenin, compared with 3 of 6 cases indefinite for <z:mpath ids='MPATH_589'>dysplasia</z:mpath> and 11 of 17 cases with low grade <z:mpath ids='MPATH_589'>dysplasia</z:mpath> (P = 0.022) </plain></SENT>
<SENT sid="6" pm="."><plain>Similar results were seen for expression of alpha-catenin (P &lt; .01) and E-cadherin (P = .049) </plain></SENT>
<SENT sid="7" pm="."><plain>In esophageal <z:mp ids='MP_0009308'>adenocarcinomas</z:mp>, preserved expression of these proteins occurred more frequently in well-differentiated <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumors</z:e>; abnormal expression was more common in diffusely infiltrative poorly differentiated <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumors</z:e> that did not form glands </plain></SENT>
<SENT sid="8" pm="."><plain>Focal nuclear staining for beta-catenin was present in two high-grade <z:mpath ids='MPATH_589'>dysplasias</z:mpath>, two intramucosal <z:mp ids='MP_0002038'>carcinomas</z:mp>, and five <z:mp ids='MP_0009308'>adenocarcinomas</z:mp> </plain></SENT>
<SENT sid="9" pm="."><plain>No survival advantage was demonstrated for patients whose <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumors</z:e> retained expression of these cell <z:e sem="disease" ids="C0001511" disease_type="Disease or Syndrome;Acquired Abnormality" abbrv="">adhesion</z:e> components </plain></SENT>
<SENT sid="10" pm="."><plain>In conclusion, abnormal expression of the E-cadherin/catenin membrane complex is common in esophageal <z:mp ids='MP_0009308'>adenocarcinoma</z:mp> and occurs early in the <z:mpath ids='MPATH_589'>dysplasia</z:mpath>/<z:mp ids='MP_0002038'>carcinoma</z:mp> sequence in <z:hpo ids='HP_0100580'>Barrett's esophagus</z:hpo>, indicating that disturbances in this cell <z:e sem="disease" ids="C0001511" disease_type="Disease or Syndrome;Acquired Abnormality" abbrv="">adhesion</z:e> complex might be important in <z:mp ids='MP_0002006'>tumorigenesis</z:mp> and <z:e sem="disease" ids="C0178874" disease_type="Neoplastic Process" abbrv="">tumor progression</z:e> in this disorder </plain></SENT>
</text></document>